The global GLP-1 market is estimated to grow from USD 49.3 billion in the current year to USD 157.5 billion by 2035, at a CAGR of 11.1% during the forecast period, till 2035
Nevertheless, individual patient factors, including the presence of other autoimmune conditions, cardiovascular risk factors, and previous tolerance of weight loss interventions, should inform the prescribing decision
Healthcare providers must educate patients on the correct administration technique to ensure optimal efficacy and safety
Finally, based on the noted beneficial effect, BPC 157 may balance collagen synthesis and affect hepatic fibrosis, as a model of the wound-healing response to chronic liver injury, which was modified (Wynn, 2008
Physicians expect a rapid shift in prescribing patterns as cheaper generics make GLP-1 therapy accessible to a much broader segment of patients
No, potency cannot be guaranteed after 28 days outside refrigeration